Effects of Brain-derived Neurotrophic Factor on 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in Monkeys

This publication has 59 references indexed in Scilit:

• Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.
  Proceedings of the National Academy of Sciences, 1992
• Function and evolution in the NGF family and its receptors
  Journal of Neuroscience Research, 1992
• Keeping track of neurotrophin receptors
  Cell, 1991
• Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain.
  Proceedings of the National Academy of Sciences, 1990
• Brain-derived neurotrophic factor prevents neuronal death in vivo
  Nature, 1988
• ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?
  The Lancet, 1986
• Regulation of microtubule composition and stability during nerve growth factor-promoted neurite outgrowth.
  The Journal of cell biology, 1986
• V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Life Sciences, 1985
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  Proceedings of the National Academy of Sciences, 1983
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979